Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluated stem cell mobilization using AMD3100 (plerixafor) plus G-CSF in patients with non-Hodgkin lymphoma and multiple my…
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil [NA]
This clinical trial update reports termination of a study evaluating tacrolimus with mycophenolate mofetil for graft-versus-host disease pro…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Injection of ex Vivo Amplified G-CSF Mobilised Autologous Peripheral Blood Stem Cell Transplantation [Phase 2]
Phase 2 trial evaluating ex vivo amplified G-CSF-mobilised autologous peripheral blood stem cell transplantation in multiple myeloma has com…
-
CLINICAL_TRIALS trial_result · 2010-11-04Clinical Trial Update: Stem Cell Transplant and Zoledronic Acid Improve Outcome in Previously Untreated Patients With Multiple Myeloma
The trial update reports that combining autologous stem cell transplant with zoledronic acid may improve outcomes in patients with previousl…
-
CLINICAL_TRIALS trial_result · 2010-11-03Clinical Trial Update: Study of AVE1642 Anti-IGF1R Monoclonal Antibody in Patients With Advanced Multiple Myeloma [Phase 1]
A completed Phase 1 trial evaluating AVE1642, an anti-IGF1R monoclonal antibody, in patients with advanced multiple myeloma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM) [Phase 1, Phase 2]
This trial update reports on the safety and anti-disease activity of CHR-2797 (tosedostat) in elderly and/or treatment-refractory patients w…
-
CLINICAL_TRIALS trial_result · 2010-10-22Clinical Trial Update: Extension Study of the Efficacy and Safety of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma [Phase 2]
This document provides an extension study update on the efficacy and safety of oral SCIO-469 in relapsed, refractory multiple myeloma (Phase…
-
CLINICAL_TRIALS trial_result · 2010-10-21Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in MM Patients to Mobilize PBCs For Collection and for Transplantation [Phase 2]
This is a Phase 2 trial evaluating plerixafor (AMD3100) to mobilize peripheral blood cells in multiple myeloma patients for collection and t…
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma [Phase 2]
Phase 2 trial evaluating anti-thymocyte globulin plus melphalan in relapsed multiple myeloma was terminated. Results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-18Clinical Trial Update: Study of Oral SCIO-469 in Relapsed, Refractory Patients With Multiple Myeloma [Phase 2]
This is a completed Phase 2 clinical trial evaluating oral SCIO-469 in relapsed, refractory multiple myeloma.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis [Phase 2]
Phase 2 clinical trial evaluating high-dose melphalan followed by peripheral stem cell transplantation in patients with amyloidosis. The stu…
-
CLINICAL_TRIALS trial_result · 2010-09-29Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) in Multiple Myeloma Patients [Phase 3]
Phase 3 trial evaluating stem cell mobilization with AMD3100 (plerixafor) in multiple myeloma has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 3]
A Phase 3 clinical trial comparing melphalan with or without Holmium-166 DOTMP, followed by peripheral stem cell transplantation, in patient…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan and busulfan conditioning followed by donor peripheral stem cell transplantation with tacrolimus and me…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Radiation Therapy Using Holmium Ho 166 DOTMP Plus Melphalan and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating Holmium-166 DOTMP plus Melphalan and peripheral stem cell transplantation in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Donor White Blood Cell Infusions and Interleukin-2 in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Relapsed Advanced Lymphoid Cancer [Phase 1, Phase 2]
This clinical trial update reports on a Phase 1/2 study evaluating donor white blood cell infusions with interleukin-2 in patients undergoin…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients [NA]
A completed clinical trial update examining the emotional needs of caregivers of stem cell transplantation patients is reported.
-
CLINICAL_TRIALS trial_result · 2010-09-14Clinical Trial Update: High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma [Phase 2]
Phase 2 trial evaluating high-dose sequential therapy with autologous stem cell rescue in multiple myeloma; study completed.
-
CLINICAL_TRIALS trial_result · 2010-08-13Clinical Trial Update: AMD3100 (Plerixafor) in Multiple Myeloma (MM) or Non-Hodgkin's Lymphoma (NHL) Patients Predicted to be Unable to Mobilize With G-CSF Alone [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in multiple myeloma or non-Hodgkin lymphoma patients predicted to be unable to mobilize with G-CSF alo…
-
CLINICAL_TRIALS trial_result · 2010-08-09Clinical Trial Update: High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin Lymphoma [Phase 2]
A Phase 2 trial evaluating high-dose busulfan and high-dose cyclophosphamide conditioning followed by donor bone marrow transplantation in p…
-
CLINICAL_TRIALS trial_result · 2010-08-02Clinical Trial Update: Study of Combination PS-341 and Thalidomide in Multiple Myeloma [Phase 1]
Phase 1 clinical trial assessing the combination of PS-341 (bortezomib) and thalidomide in patients with multiple myeloma; the study status …
-
CLINICAL_TRIALS trial_result · 2010-07-14Clinical Trial Update: Mobilization of Stem Cells With Plerixafor, Chemotherapy and G-CSF in Multiple Myeloma or Non-Hodgkin's Lymphoma Patients [Phase 2]
Phase 2 trial evaluating stem cell mobilization using plerixafor in combination with chemotherapy and G-CSF in patients with multiple myelom…
-
CLINICAL_TRIALS trial_result · 2010-07-08Clinical Trial Update: Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma [Phase 2]
A Phase 2 clinical trial evaluating pegfilgrastim for stem cell mobilization in lymphoma and multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2010-07-07Clinical Trial Update: Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally [Phase 2]
A Phase 2 clinical trial evaluating a tumor antigen-pulsed autologous dendritic cell vaccine administered subcutaneously or intranodally in …
-
CLINICAL_TRIALS trial_result · 2010-07-05Clinical Trial Update: Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Phase 2]
A Phase 2 clinical trial evaluating the combination of pamidronate and thalidomide for multiple myeloma has completed.